Cargando…

Gut microbiota distinct between colorectal cancers with deficient and proficient mismatch repair: A study of 230 CRC patients

Colorectal cancers (CRCs) with deficient DNA mismatch repair (dMMR) and proficient DNA mismatch repair (pMMR) exhibit heterogeneous tumor characteristics, distinct responses to immunotherapy, and different survival outcomes. However, it is unclear whether gut microbiota is distinct between CRCs with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Min, Wu, Jingjing, Shi, Linli, Zhou, Bin, Shang, Fumei, Chang, Xiaona, Dong, Xiaochuan, Deng, Shenghe, Liu, Li, Cai, Kailin, Nie, Xiu, Zhang, Tao, Fan, Jun, Liu, Hongli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607965/ https://www.ncbi.nlm.nih.gov/pubmed/36312959 http://dx.doi.org/10.3389/fmicb.2022.993285

Ejemplares similares

Changes in Bacteroides and the microbiota in patients with obstructed colorectal cancer: retrospective cohort study
por: Cao, Yinghao, et al.
Publicado: (2023)

Tumor-Associated Microbiota in Proximal and Distal Colorectal Cancer and Their Relationships With Clinical Outcomes
por: Jin, Min, et al.
Publicado: (2021)

Development and Interpretation of a Clinicopathological-Based Model for the Identification of Microsatellite Instability in Colorectal Cancer
por: Jiang, Zhenxing, et al.
Publicado: (2023)

Microbial Characteristics of Locally Advanced Rectal Cancer Patients After Neoadjuvant Chemoradiation Therapy According to Pathologic Response
por: Fan, Qilin, et al.
Publicado: (2021)

Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers
por: Hale, Vanessa L., et al.
Publicado: (2018)

Immunoscore in mismatch repair‐proficient and ‐deficient colon cancer
por: Wirta, Erkki‐Ville, et al.
Publicado: (2017)

Robust Glycogene-Based Prognostic Signature for Proficient Mismatch Repair Colorectal Adenocarcinoma
por: Li, Yixi, et al.
Publicado: (2021)

The Prognostic Significance of RIMKLB and Related Immune Infiltrates in Colorectal Cancers
por: Cao, Yinghao, et al.
Publicado: (2022)

CRC-Aided Adaptive BP Decoding of PAC Codes
por: Zhang, Xianwen, et al.
Publicado: (2022)

Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells
por: Schwarz, V A, et al.
Publicado: (2002)

Associations between diet, gut microbiota and markers of CRC risk
por: Culpepper, Tyler, et al.
Publicado: (2014)

A230 THE ROLE OF THE MICROBIOTA IN NOCICEPTOR DEVELOPMENT AND PAIN SENSITIVITY
por: Abdullah, N, et al.
Publicado: (2022)

Microbiome distinctions between the CRC carcinogenic pathways
por: DeDecker, Lauren, et al.
Publicado: (2021)

Development and Validation of a Predictive Scoring System for Colorectal Cancer Patients With Liver Metastasis: A Population-Based Study
por: Cao, Yinghao, et al.
Publicado: (2021)

Quantitative assessment of tumor-infiltrating lymphocytes in mismatch repair proficient colon cancer
por: Jimenez-Rodriguez, Rosa M., et al.
Publicado: (2020)

Risk for Hereditary Neoplastic Syndromes in Women with Mismatch Repair-Proficient Endometrial Cancer
por: dos Santos, Jennifer Thalita Targino, et al.
Publicado: (2023)

Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2022)

Collective states in $^{230}$Ra fed by beta- decay of $^{230}$Fr
por: Kurcewicz, W, et al.
Publicado: (1986)

Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients
por: Liu, Shou-Sheng, et al.
Publicado: (2018)

Fission of $^{230}$Ac
por: Kaw\k{e}cka, Anna, et al.
Publicado: (2023)

Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer
por: Eppenberger, Manuela, et al.
Publicado: (2010)

Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
por: Swan, Rebecca, et al.
Publicado: (2016)

Immuno-Contexture and Immune Checkpoint Molecule Expression in Mismatch Repair Proficient Colorectal Carcinoma
por: Giacomelli, Mauro, et al.
Publicado: (2023)

Frequency of Mismatch Repair Protein (MMRP) Deficiency among Young Jordanians Diagnosed with Colorectal Carcinoma (CRC)
por: Maraqa, Bayan, et al.
Publicado: (2020)

IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer
por: Rong, Yu-ming, et al.
Publicado: (2023)

Depicting the landscape of gut microbial-metabolic interaction and microbial-host immune heterogeneity in deficient and proficient DNA mismatch repair colorectal cancers
por: Li, Jinming, et al.
Publicado: (2023)

Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
por: Nehmé, A, et al.
Publicado: (1999)

Efficient engineering of chromosomal ribosome binding site libraries in mismatch repair proficient Escherichia coli
por: Oesterle, Sabine, et al.
Publicado: (2017)

Collective states in $^{230}$Ra
por: Kurcewicz, W, et al.
Publicado: (1986)

Health Tract, No. 230: Cough
Publicado: (1865)

FRI230 Cystic Pheochromocytoma
por: Saberi, Sima
Publicado: (2023)

Immunolocalization of a novel, cytoskeleton-associated polypeptide of Mr 230,000 daltons (p230)
Publicado: (1983)

Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer
por: Kasi, Pashtoon Murtaza, et al.
Publicado: (2023)

BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors
por: Fu, Yu, et al.
Publicado: (2023)

$\beta$-delayed fission of $^{230}$Am
por: Wilson, G L, et al.
Publicado: (2017)

A Record Distribution: £230,000
Publicado: (1919)

Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
por: Ho, William W., et al.
Publicado: (2021)

Identification and decay of /sup 190/W, /sup 196/Os, /sup 230/Ra, and /sup 230/Ac
por: Katcoff, S, et al.
Publicado: (1976)

Microsatellite stability and mismatch repair proficiency in nasopharyngeal carcinoma may not predict programmed death-1 blockade resistance
por: Liao, Xiyi, et al.
Publicado: (2017)

Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer
por: Liu, Shousheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lj9v0sdnfv96hr5oqj182oi3f8